GlassScriptPhysician profile
Zain Hyder
NPI 1306343892
$4,970.98
in general payments reported to CMS, 2019-2025
23 companies · $908 in 2025
The $908 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.96 · 2020: $200 · 2021: $112 · 2022: $457 · 2023: $1,134 · 2024: $2,083 · 2025: $908.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,386 · Travel and Lodging: $739.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,386.30 |
| Travel and Lodging | $738.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,667.27 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Boston Scientific Corporation | $1,093.23 | 2019-2025 | Spaceoar Vue System - 10ml, Lithovue, Rezum Generator |
| Coloplast Corp | $530.58 | 2023-2024 | Titan, Altis |
| Sumitomo Pharma America, INC. | $266.21 | 2024-2025 | Gemtesa, Orgovyx |
| Axonics, INC. | $214.37 | 2023-2024 | Axonics, Bulkamid |
| Urogen Pharma, INC. | $213.28 | 2022-2025 | Jelmyto |
| Pfizer INC. | $135.86 | 2020-2024 | |
| Janssen Biotech, INC. | $116.73 | 2024 | Erleada, Akeega |
| Merck Sharp & Dohme LLC | $115.58 | 2024 | Keytruda, Lynparza |
| Abbvie INC. | $99.83 | 2024-2025 | |
| Intuitive Surgical, INC. | $95.58 | 2022 | |
| Endo USA, INC. | $70.18 | 2024-2025 | Xiaflex, Aveed |
| Olympus America INC. | $61.60 | 2024 | Itind System |
| Tolmar, INC. | $61.12 | 2024-2025 | Eligard, Jatenzo |
| Astellas Pharma US INC | $47.07 | 2023 | Myrbetriq |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Immunitybio, INC. | $34.88 | 2025 | |
| Teleflex LLC | $30.18 | 2024 | Urolift |
| Progenics Pharmaceuticals, INC. | $23.43 | 2025 | |
| Antares Pharma, INC. | $20.72 | 2023 | Nocdurna, Tlando, Xyosted |
| Dexcom, INC. | $20.69 | 2024 | Dexcom G6 Transmitter |
| Endo Pharmaceuticals INC. | $20.20 | 2023 | Xiaflex, Aveed |
| Novartis Pharmaceuticals Corporation | $19.09 | 2025 | |
| Medtronic, INC. | $13.30 | 2024 | Interstim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Zain Hyder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.